Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Political science and global health policy

Gómez EJ, Singh P, Shiffman J, et al. Elsevier BV. The Lancet. 2022;
Download PDF
Publication

Safety and Tolerability of Ivermectin and Albendazole Mass Drug Administration in Lymphatic Filariasis Endemic Communities of Tanzania: A Cohort Event Monitoring Study

Fimbo AM, Minzi OM, Mmbando BP, et al. MDPI AG. Pharmaceuticals. 2022; 15 (5) : 594.
Download PDF
Publication

Monitoring the elimination of <i>gambiense</i> human African trypanosomiasis in the historical focus of Batié, South–West Burkina Faso

Compaoré CFA, Kaboré J, Ilboudo H, et al. EDP Sciences. Parasite. 2022;
Download PDF
Publication

Leaving no one behind: targeting mobile and migrant populations with health interventions for disease elimination—a descriptive systematic review

Adams MW, Sutherland EG, Eckert EL, et al. Springer Science and Business Media LLC. BMC Medicine. 2022;
Download PDF
Publication

Impact of intensified control on visceral leishmaniasis in a highly-endemic district of Bihar, India: an interrupted time series analysis

Kumar V, Siddiqui NA, Pollington TM, et al. Elsevier BV. Epidemics. 2022;
Download PDF
Publication

Targeting research to address societal needs: What can we learn from 30 years of targeting neglected diseases?

Coburn J, Yaqub O, Chataway J. Center for Open Science. 2022;
Download PDF
Publication

Neglected tropical diseases in Australia: a narrative review.

Kurcheid J, Gordon C, Clarke N, et al. The Medical journal of Australia. 2022;
Publication

Digital Health and Artificial Intelligence: Advancing Healthcare Provision in Latin America

Garcia Alonso R, Thoene U, Davila Benavides D. Institute of Electrical and Electronics Engineers (IEEE). IT Professional. 2022; 24 (2) : 62-68.
Publication

A safe, effective, and reliable vaccine against Chagas disease should be described!

Silva JS. FapUNIFESP (SciELO). Memórias do Instituto Oswaldo Cruz. 2022;
Download PDF
Publication

Cohort Profile: The 100 Million Brazilian Cohort

Barreto ML, Ichihara MY, Pescarini JM, et al. Oxford University Press (OUP). International Journal of Epidemiology. 2021; 51 (2) : e27-e38.
Download PDF

Pagination

  • Previous page ‹ ‹ Previous
  • …
  • Page 329
  • Page 330
  • Page 331
  • Page 332
  • Current page 333
  • Page 334
  • Page 335
  • Page 336
  • Page 337
  • …
  • Next page Next › ›
  • Last page Last » »
Subscribe to

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2025 InfoNTD